KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HCA Healthcare (HCA) Change in Accured Expenses (2016 - 2025)

Historic Change in Accured Expenses for Healthcare (HCA) over the last 12 years, with Q4 2025 value amounting to $637.0 million.

  • Healthcare's Change in Accured Expenses rose 12588.65% to $637.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $666.0 million, marking a year-over-year increase of 8551.53%. This contributed to the annual value of $666.0 million for FY2025, which is 8551.53% up from last year.
  • Per Healthcare's latest filing, its Change in Accured Expenses stood at $637.0 million for Q4 2025, which was up 12588.65% from $705.0 million recorded in Q3 2025.
  • Healthcare's Change in Accured Expenses' 5-year high stood at $716.0 million during Q3 2023, with a 5-year trough of -$1.1 billion in Q1 2023.
  • Over the past 5 years, Healthcare's median Change in Accured Expenses value was $303.0 million (recorded in 2024), while the average stood at $116.6 million.
  • As far as peak fluctuations go, Healthcare's Change in Accured Expenses crashed by 11119.05% in 2022, and later surged by 129361.7% in 2023.
  • Over the past 5 years, Healthcare's Change in Accured Expenses (Quarter) stood at $268.0 million in 2021, then rose by 29.85% to $348.0 million in 2022, then rose by 12.93% to $393.0 million in 2023, then dropped by 28.24% to $282.0 million in 2024, then surged by 125.89% to $637.0 million in 2025.
  • Its Change in Accured Expenses stands at $637.0 million for Q4 2025, versus $705.0 million for Q3 2025 and $324.0 million for Q2 2025.